Standout Papers

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promi... 2016 2026 2019 2022 723
  1. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1 (2016)
    Yusuke Ogitani, Tetsuo Aida et al. Clinical Cancer Research

Immediate Impact

8 by Nobel laureates 12 from Science/Nature 58 standout
Sub-graph 1 of 21

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout

Works of Tetsuo Aida being referenced

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
2016 Standout

Author Peers

Author Last Decade Papers Cites
Tetsuo Aida 427 347 169 774 450 102 1.8k
Zhaoda Zhang 235 95 102 577 327 111 2.0k
Yasushi Kato 296 114 182 176 330 70 1.7k
Meera Venkatesh 230 44 143 420 1708 134 2.7k
Alessandra Boschi 268 26 329 353 1138 93 2.1k
Rubel Chakravarty 59 56 360 351 1657 136 2.6k
M.R.A. Pillai 176 30 72 601 2020 102 2.8k
Anthony R. Martin 1205 76 47 216 110 88 2.4k
Aleksander Bilewicz 64 64 271 181 1097 100 1.8k
Tapas Das 144 36 68 486 1393 148 2.3k
Kouji Tanaka 91 87 136 334 78 104 1.6k

All Works

Loading papers...

Rankless by CCL
2026